Exagen Inc (XGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Exagen Inc-Aktie (XGN)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.72% 14.41	13.77	13.42	14.14	11.23
Cost Of Revenue	3.51% 5.817	5.62	5.71	5.836	5.926
Gross Profit	5.56% 8.598	8.145	7.706	8.301	5.304
Operating Expenses	12.72% 11.60	13.29	12.78	13.22	13.01
Interest Income/Expense	3.00% 0.549	0.566	0.557	0.574	0.638
Benefits Costs and Expenses	7.90% 17.42	18.91	18.48	19.05	18.94
Costs And Expenses	7.90% 17.42	18.91	18.48	19.05	18.94
Operating Income/Loss	41.66% -3.003	-5.147	-5.069	-4.915	-7.706
Income/Loss From Continuing Operations Before Tax	41.66% -3.003	-5.147	-5.069	-5.013	-7.688
Income/Loss From Continuing Operations After Tax	39.71% -3.36	-5.573	-5.415	-5.013	-7.688
Net Income/Loss	39.71% -3.36	-5.573	-5.415	-5.013	-7.688
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	33,898% 17.94	0.0528	17.69	17.66	17.53
Diluted Average Shares	33,898% 17.94	0.0528	17.69	17.66	17.53
Basic Earnings Per Share	38.71% -0.19	-0.31	-0.31	-0.28	-0.44
Diluted Earnings Per Share	38.71% -0.19	-0.31	-0.31	-0.28	-0.44
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

$239.67

0.21%

NTRA

$167.26

1.24%

WAT

$373.47

1.35%

ILMN

$140.14

2.30%

MTD

$1,217.97

1.77%

IDXX

$417.24

0.31%